Trading Statement, Upcoming Earnings Release, Quarterly Earnings, and CSR Initiative - Research Reports on Unilever, SodaStream, Carlisle Companies, PVH and Lear

NEW YORK, October 29, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Unilever plc (NYSE: UL), SodaStream International Ltd. (NASDAQ: SODA), Carlisle Companies Incorporated (NYSE: CSL), PVH Corp. (NYSE: PVH) and Lear Corp. (NYSE: LEA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7526-100free.

--
Unilever plc Research Reports
On October 23, 2014, Unilever plc (Unilever) released a trading statement for Q3 2014. The underlying sales and volume for the quarter increased 2.1% and 0.3%, respectively. The Company's underlying sales growth in emerging markets slowed to 5.6% whilst developed markets declined by 2.5% in Q3 2014. Sharp market slow-down in China led to trade de-stocking across the distribution channels, resulting in a decline of around 20% in the Company's underlying sales. Q3 2014 growth was sluggish in Unilever's personal care category due to slower markets, however, the segment benefitted from the launch of Rexona Anti-bacterial Protection in Latin America and the success of the compressed aerosol range in Europe and strong performance of Dove. In Q3 2014, Unilever's Foods segment witnessed growth in savoury and dressings and Knorr delivered a strong programme of innovation with multiple product launches, but this was insufficient to offset the overall decline of the category caused by fall in the margarine market and price deflation in a weak commodity costs environment. The Home care section observed good growth with successful launch of a range stain removers and pre-treaters under the Omo brand in Brazil. The full research reports on Unilever are available to download free of charge at:

http://www.analystsreview.com/Oct-29-2014/UL/report.pdf

--
SodaStream International Ltd. Research Reports
On October 22, 2014, SodaStream International Ltd. (SodaStream) announced that it plans to release its Q3 2014 financial results on October 29, 2014 at around 7:30 a.m. ET, which will be followed by a conference call at 8:30 a.m. ET. Analysts polled by Bloomberg Businessweek forecast an EPS (Pre-Exceptional) of $0.70 on revenue of $154 million for Q3 2014. The full research reports on SodaStream are available to download free of charge at:

http://www.analystsreview.com/Oct-29-2014/SODA/report.pdf

--
Carlisle Companies Incorporated Research Reports
On October 21, 2015, Carlisle Companies Incorporated (Carlisle Companies) reported its Q3 2014 results. Net sales for the quarter were $904.1 million, up 13.5% YoY, led by Carlisle Construction Materials (CCM), which reported net sales of $589.1 million, up 16.5% YoY, reflecting higher sales volume of roofing systems and polyiso applications, marginally offset by lower selling price. Net income came in at $87.3 million, up 14.0% YoY with diluted EPS of $1.32 as compared to $1.17 in Q3 2013. David A. Roberts, Chairman and CEO, said "We maintain our favorable outlook for the remainder of 2014 driven primarily by continued growth at CCM and Carlisle Interconnect Technologies. We continue to plan for high single-digit percentage sales growth for 2014 as well as higher EBIT and EBIT margin expansion. In addition, the two acquisitions we announced are excellent strategic fits and align with our long term growth and margin profiles." The full research reports on Carlisle Companies are available to download free of charge at:

http://www.analystsreview.com/Oct-29-2014/CSL/report.pdf

--
PVH Corp. Research Reports
On September 17, 2014, PVH Corp. (PVH) announced a year-long campaign to raise funds for My Hope Chest in honor of Breast Cancer Awareness month October 2014. My Hope Chest is the national not for profit organization which funds breast reconstruction for uninsured and under insured survivors. According to the Company, consumers willing to help can support the cause by visiting a dedicated page on the Olga(women's intimates brand owned by PVH) website to donate an amount of their choice, which will be matched by the Company in the brand's name up to $75,000. The full research reports on PVH are available to download free of charge at:

http://www.analystsreview.com/Oct-29-2014/PVH/report.pdf

--
Lear Corp. Research Reports
On October 24, 2014, Lear Corp. (Lear) reported financial results for Q3 FY 2014 (period ended September 27, 2014). The net sales for the quarter were $4.2 billion, up 8.0% YoY and net income came in at $140.1 million, up 24.2% YoY with diluted EPS of $1.72, as compared to $1.38 in Q3 FY 2013. During the quarter, the Company repurchased 1.0 million shares of its common stock for a total of $103 million. In the Seating segment, sales were $3.2 billion up 10.3% YoY, reflecting the addition of new business and higher production on key platforms. The Company expects sales in FY 2014 to be c.$17.7 billion, and Core operating earnings for the fiscal are expected to be in the range of $1,010 to $1,040 million, up from the prior range of $975 to $1,025 million. The full research reports on Lear are available to download free of charge at:

http://www.analystsreview.com/Oct-29-2014/LEA/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review